Patents by Inventor Joan Montaner Vilallonga

Joan Montaner Vilallonga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150276763
    Abstract: The invention relates to methods for determining the clinical outcome of a patient suffering ischemic stroke, for designing an individual therapy and for diagnosing a silent cerebrovascular disease comprising determining the levels of a marker selected from DPYSL2, gelsolin, CysA, or a combination thereof, the altered expression of which in relation to a reference value allows determining the clinical outcome of a patient suffering ischemic stroke, designing for designing an individual therapy or diagnosing a silent cerebrovascular disease. Furthermore, the invention relates to a kit comprising a reagent for detecting the level of a marker selected from DPYSL2, gelsolin, CysA, or a combination thereof and to the use of the said kit in the methods of the invention.
    Type: Application
    Filed: October 24, 2013
    Publication date: October 1, 2015
    Applicant: FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA
    Inventors: Teresa García-Berrocoso, Joan Montaner Vilallonga
  • Patent number: 8906642
    Abstract: The invention provides a method for predicting a hemorrhagic disorder in a patient consisting determining amine oxidase and, particularly, VAP-1 in a sample from said patient. The invention also provides pharmaceutical compositions comprising an inhibitor of amine oxidase and an antithrombotic agent as well as the use of an inhibitor of amine oxidase for treatment of hemorrhagic disorders.
    Type: Grant
    Filed: September 2, 2009
    Date of Patent: December 9, 2014
    Assignee: Universitat Autonoma de Barcelona
    Inventors: Joan Montaner Vilallonga, Mar Hernández-Guillamón, Mercedes Unzeta López
  • Publication number: 20120014939
    Abstract: The invention provides a method for predicting a hemorrhagic disorder in a patient consisting determining amine oxidase and, particularly, VAP-1 in a sample from said patient. The invention also provides pharmaceutical compositions comprising an inhibitor of amine oxidase and an antithrombotic agent as well as the use of an inhibitor of amine oxidase for treatment of hemorrhagic disorders.
    Type: Application
    Filed: September 2, 2009
    Publication date: January 19, 2012
    Inventors: Joan Montaner Vilallonga, Mar Hernández-Guillamón, Mercedes Unzeta López
  • Publication number: 20110294690
    Abstract: The present invention relates to the identification and use of diagnostic markers related with brain damage, particularly, biomarkers independently selected from the group consisting of interleukin-17 (IL-17), Fas ligand (FasL), b nerve growth factor (bNGF), insulin growth factor binding protein 3 (IGFBP3), p55 tumour necrosis factor receptor (TNFR-1), growth-related oncogene alpha (GroA), interleukin-2 soluble receptor gamma (IL2RG) and combinations thereof, that are associated with the diagnosis, prognosis, or differentiation of stroke mimicking conditions and stroke in a subject.
    Type: Application
    Filed: September 17, 2009
    Publication date: December 1, 2011
    Applicant: FUNDACIO INSTITUT DE RECERCA DE L'HOSPITAL UNIVERSITARI VALL D'HEBRON
    Inventor: Joan Montaner Vilallonga